FULC insider transaction filings

Fulcrum Therapeutics, Inc. — 35 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-20. Screen FULC transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-204TANG KEVIN — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
Purchase (P): 116,671 @ $3.56 · Purchase (P): 50,945 @ $3.52EDGAR
2026-07-154TANG KEVIN — 10% owner
TANG CAPITAL MANAGEMENT LLC — 10% owner
Purchase (P): 12,966 @ $3.54 · Purchase (P): 53,651 @ $3.56 · Purchase (P): 75,952 @ $3.58 · Purchase (P): 107,377 @ $3.56EDGAR
2026-07-024Banks Sonja — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024Ezekowitz Alan — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024Hill Colin — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024Haviland Kate — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024Dorton Katina — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024King Rachel K. — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024Gould Robert J — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-07-024GERAGHTY JAMES A — DirectorGrant/award (A): 32,000 (derivative) @ $0EDGAR
2026-06-304Ezekowitz Alan — DirectorSale (S): 18,000 @ $3.65EDGAR
2026-05-014Lehrer-Graiwer Joshua — DirectorGrant/award (A): 64,000 (derivative) @ $0EDGAR
2026-02-044Oltmans Curtis Gale — Chief Legal OfficerGrant/award (A): 170,000 (derivative) @ $0EDGAR
2026-02-044Tourangeau Greg — Principal Accounting OfficerGrant/award (A): 57,000 (derivative) @ $0EDGAR
2026-02-044Sapir Alex — See Remarks, DirectorGrant/award (A): 650,000 (derivative) @ $0EDGAR
2026-02-044Gould Robert J — DirectorSale (S): 15,000 @ $10.72EDGAR
2026-02-044/AGould Robert J — DirectorSale (S): 15,000 @ $10.87EDGAR
2026-02-044Musso Alan A — Chief Financial OfficerGrant/award (A): 170,000 (derivative) @ $0EDGAR
2026-01-064Gould Robert J — DirectorSale (S): 15,000 @ $11.87EDGAR
2025-12-174Oltmans Curtis Gale — Chief Legal OfficerSale (S): 3,452 @ $12.92EDGAR
2025-12-104RA CAPITAL MANAGEMENT, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner
Sale (S): 1,377,020 @ $13.33 · Sale (S): 2,706,397 @ $14.28 · Sale (S): 91,722 @ $14.98EDGAR
2025-11-214Gould Robert J — DirectorSale (S): 15,000 @ $11.03EDGAR
2025-06-304Banks Sonja — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304Ezekowitz Alan — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304Hill Colin — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304Haviland Kate — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304Dorton Katina — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304King Rachel K. — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304Gould Robert J — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-06-304GERAGHTY JAMES A — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2025-05-094Tourangeau Greg — Principal Accounting OfficerSale (S): 498 @ $5.06EDGAR
2025-01-284Sapir Alex — See Remarks, DirectorGrant/award (A): 582,000 (derivative) @ $0EDGAR
2025-01-284Tourangeau Greg — Principal Accounting OfficerGrant/award (A): 76,120 (derivative) @ $0EDGAR
2025-01-284Oltmans Curtis Gale — Chief Legal OfficerGrant/award (A): 225,000 (derivative) @ $0EDGAR
2025-01-284Musso Alan A — Chief Financial OfficerGrant/award (A): 285,000 (derivative) @ $0EDGAR

Recent 8-K events — Fulcrum Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-178-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-048-K?
8.01 — Other Events
EDGAR
2026-06-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K1.02 — Termination of a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-248-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-118-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FULC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →